Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1 clinical trials
CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children

Study of adding anti-CD20 antibody (rituximab) with chemotherapy: CD20 is found to be expressed in 40-50% of B-lineage ALL, and rituximab has been studied in adult ALL with superior survival (75% vs 47%,). There is little experience of using rituximab in pediatric ALL thus a CCCG Relapsed ALL 2017 Study …

leukemic cells
proteasome inhibitor
acute lymphoblastic leukemia
pediatric
hematopoietic stem cell transplantation
  • 0 views
  • 19 Feb, 2024